Tony Liu, Director at Cellular Biomedicine Group, Inc. (CBMG), bought 700 shares at $5.00 ($4K) on 2013-04-16, disclosed to the SEC on 2013-04-17.
Open-market purchase of $4k CBMG by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| CBMG | BUY | 2014-05-30 | $500K | — | Filing → |
| AOB | BUY | 2007-03-16 | $189K | — | Filing → |
| AOB | BUY | 2007-03-15 | $260K | — | Filing → |